Foley导尿管序贯米索前列醇与单用米索前列醇用于引产的多中心随机对照试验
该多中心随机对照试验在哈萨克斯坦阿拉木图2家医院纳入400例足月、单胎、头先露、宫颈条件不佳(改良Bishop评分≤6)需引产的孕妇,比较Foley导尿管序贯米索前列醇与单用米索前列醇的引产效果与安全性。序贯法提高阴道分娩概率(77.5% vs 69.5%;校正RR=1.16;95%CI:1.04-1.29;P=.009),米索前列醇总剂量更低,但绒毛膜羊膜炎发生率更高(OR=3.82;95%CI:1.05-13.9;P=.03)。
要点
- 序贯法阴道分娩率77.5%,单用米索前列醇组69.5%(校正RR=1.16;95%CI:1.04-1.29;P=.009)。
- 序贯组米索前列醇总剂量显著低于单用组(P<.001)。
- 序贯组绒毛膜羊膜炎发生率更高(OR=3.82;95%CI:1.05-13.9;P=.03),作者认为需进一步研究。
核心结论
- 序贯法提高阴道分娩概率且所需米索前列醇总剂量更低,未增加主要母儿并发症。
- 但序贯法可能与更高的绒毛膜羊膜炎风险相关,作者认为需进一步研究。
- 作者认为该结果支持将序贯法作为宫颈条件不佳孕妇引产的一种临床有效且药理学上保守的替代方案加以考虑。
研究设计与样本
- 多中心随机对照试验(NCT06249815),在哈萨克斯坦阿拉木图2家医院开展。
- 纳入400例足月单胎、头先露、改良Bishop评分≤6、需引产的孕妇。
主要发现
- 序贯法组阴道分娩率77.5%,单用米索前列醇组69.5%(校正RR=1.16;95%CI:1.04-1.29;P=.009)。
- 序贯组米索前列醇总剂量显著低于单用组(P<.001)。
- 序贯组绒毛膜羊膜炎发生率更高(OR=3.82;95%CI:1.05-13.9;P=.03)。
关键数值与推荐
- 主要结局为阴道分娩。
- 次要结局包括剖宫产、子宫过度刺激、胎儿窘迫、Apgar评分、产后出血、绒毛膜羊膜炎、会阴创伤、阴道助产、输血和引产加强。
- 宫颈条件不佳定义为改良Bishop评分≤6。
临床怎么用
- 作者认为序贯法可作为宫颈条件不佳孕妇引产的一种临床有效且药理学上保守的替代方案加以考虑。
- 作者指出序贯法可能与更高的绒毛膜羊膜炎风险相关,需进一步研究。
局限性
- 作者指出序贯法可能与更高的绒毛膜羊膜炎风险相关,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Labor induction is a critical intervention used when prolonging pregnancy poses risks to maternal or fetal health. While combined methods of cervical ripening have been studied, evidence specifically regarding sequential use (as opposed to simultaneous administration) remains limited. OBJECTIVE: To compare the efficacy and safety of a sequential labor induction method (Foley catheter followed by misoprostol) versus misoprostol alone in term pregnancies. STUDY DESIGN: This multicenter, randomized controlled trial (NCT06249815) was conducted at 2 hospitals in Almaty, Kazakhstan. A total of 400 women with singleton term pregnancies, cephalic presentation, and unfavorable cervices (Modified Bishop Score ≤6) requiring labor induction were enrolled. Participants were randomly assigned to: PRIMARY OUTCOME: Vaginal delivery. SECONDARY OUTCOMES: Cesarean delivery, uterine hyperstimulation, fetal distress, Apgar scores, postpartum hemorrhage, chorioamnionitis, perineal trauma, operative vaginal birth, blood transfusion, and labor augmentation. RESULTS: The sequential method significantly increased the probability of vaginal delivery compared to misoprostol alone (77.5% vs 69.5%; adjusted RR=1.16; 95% CI: 1.04-1.29; P=.009). The total dose of misoprostol required was significantly lower in the sequential group (P<.001). A higher incidence of chorioamnionitis was observed in the sequential group (OR=3.82; 95% CI: 1.05-13.9; P=.03). CONCLUSION: The sequential method increases the probability of vaginal delivery while requiring a lower total misoprostol dose, without increasing the rate of major maternal or neonatal complications. However, it may be associated with a higher risk of chorioamnionitis, which warrants further investigation. These findings support its consideration as a clinically effective and pharmacologically conservative alternative for labor induction in women with an unfavorable cervix.
引用
- Issenova S, Sultanmuratova D, Issina G, et al. Sequential use of foley catheter and misoprostol versus misoprostol alone for induction of labor: a multicenter randomized controlled trial. Am J Obstet Gynecol MFM. 2025. PMID: 40865800. doi:10.1016/j.ajogmf.2025.101769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。